Evert B. Schimmelpennink
President, CEO and Secretary at LENZ Therapeutics Inc.
Sits on 3 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2024
7 years of board service in total across 3 boards, counting each seat separately. Longest: LENZ Therapeutics Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Contineum Therapeutics Inc. June 26, 202699.4%
-
LENZ Therapeutics Inc. June 12, 202698.9%
-
iBio Inc. November 21, 202494.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | LENZ Therapeutics Inc. | Open-market purchase | +28,089 | $8.95 | $251,397 |
| Mar 7, 2025 | LENZ Therapeutics Inc. | Option exercise | +4,200 | $1.04 | $4,368 |
| Jul 22, 2024 | LENZ Therapeutics Inc. | Option exercise | +45,000 | $1.04 | $46,800 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.